Effective immunity hinges on the ability to sense infection and cellular transformation. In humans, there is a specialized molecule on the surface of cells termed MR1. MR1 allows sensing of certain small molecule metabolites derived from cellular and microbial sources; however, the breadth of metabolite sensing is unclear. Researchers have identified a form of vitamin B6 bound to MR1 as a means of engaging tumor-reactive immune cells.
Quelle: ScienceDaily | Immunsystem
Titelbild/Grafik: ScienceDaily News
Kommentare und Fragen
Möchten Sie zu diesem Inhalt ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!
Weiteres von ScienceDaily | Allergy
- Ultrasound-directed microbubbles could boost immune response against tumors
- Scientists develop tiny anticancer weapon
- 'Perfect storm' of mutations drives infection-triggered autoimmune disease
- Three drug cocktail shows potential to boost CAR-T cancer therapy
- A battle of rafts: How molecular dynamics in CAR T cells explain their cancer-killing behavior
- Immunotherapy against cancer: How therapeutic antibodies do their job
- T cells' capability to fully prevent acute viral infections opens new avenues for vaccine development
- Researchers shed light on how to predict which skin cancer patients are most likely to respond to immunotherapy
- Scientists unveil surprising human vs mouse differences in a major cancer immunotherapy target
- Targeting tristetraprolin in basophils: A breakthrough in allergic inflammation treatment
